Profit Margin (Quarterly) Chart

View Profit Margin (Quarterly) for BIMI.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Profit Margin (Quarterly) Chart
Start Trial

Historical Profit Margin (Quarterly) Data

View and export this data back to 2006. Start Trial.
Date Value
September 30, 2023 -124.2%
June 30, 2023 21.13%
March 31, 2023 -26.91%
September 30, 2022 -62.84%
June 30, 2022 -217.0%
March 31, 2022 -109.6%
December 31, 2021 -1.58K%
September 30, 2021 -12.41%
June 30, 2021 -2.98%
March 31, 2021 -151.8%
September 30, 2020 -60.19%
June 30, 2020
March 31, 2020 -324.9%
September 30, 2019 -262.8%
June 30, 2019 -264.7%
March 31, 2019
December 31, 2018 -307.3%
September 30, 2018 -28.56%
June 30, 2018 -292.7%
March 31, 2018 -343.3%
December 31, 2017 -10.01%
September 30, 2017 -37.39%
June 30, 2017 -15.58%
March 31, 2017 -40.95%
December 31, 2016 -25.72%
Date Value
September 30, 2016 -27.25%
June 30, 2016 -40.44%
March 31, 2016 -34.80%
December 31, 2015 -47.22%
September 30, 2015 -0.25%
June 30, 2015 -9.16%
March 31, 2015 -7.29%
December 31, 2014 -12.48%
September 30, 2014 11.13%
June 30, 2014 -23.46%
March 31, 2014 -6.27%
December 31, 2013 -13.85%
September 30, 2013 -1.89%
June 30, 2013 3.52%
March 31, 2013 0.75%
December 31, 2012 2.25%
September 30, 2012 0.06%
June 30, 2012 0.57%
March 31, 2012 0.01%
December 31, 2011 24.50%
September 30, 2011 2.74%
June 30, 2011 10.20%
March 31, 2011 11.18%
December 31, 2010 6.82%
September 30, 2010 25.73%

Profit Margin Definition

Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.

Read full definition.

Profit Margin (Quarterly) Range, Past 5 Years

View Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Profit Margin (Quarterly) Benchmarks

View Profit Margin (Quarterly) Benchmarks
Start Trial
Cencora, Inc. 2.08%
Cardinal Health, Inc. 0.62%
McKesson Corp. 1.93%
Amexdrug Corp. 2.85%
Henry Schein, Inc. 3.33%